TrialWire launches StudyBoost, the Clinical trial insurance plan

TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost...

March 23, 2021 | Tuesday | News
UK conducts innovative COVID-19 trials with deliberate volunteered infection

United Kingdom government announced an investment of 33.6 million pounds ($43.5 million) in a study called “h...

March 2, 2021 | Tuesday | News
Panthera to evaluate AstraZeneca's AZD7442 for the potential prevention of COVID-19

Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase...

December 30, 2020 | Wednesday | News
Tychan to begin Ph 3 trial for mAb TY027 against COVID-19

In June 2020, Tychan began its Phase 1 clinical safety trials in humans to evaluate TY027, a monoclonal antibo...

December 14, 2020 | Monday | News
Contract for innovative delivery system for COVID-19 vaccine

Croda International Plc (“Croda” or “the Group”), the speciality chemical company that uses smar...

November 16, 2020 | Monday | News
CEPI funds Sichuan Clover for COVID-19 vaccine development

CEPI, the Coalition for Epidemic Preparedness Innovations, based in Norway, has announced that it will fund the developm...

November 5, 2020 | Thursday | News
Russia- Destination of choice for Asian pharma companies

Asian biotech industry has been experiencing an escalating boom over the past several years. Pharmaceutical companies ha...

November 3, 2020 | Tuesday | Opinion
Daewoong pharma partners with Tufts medical center for Ph 2 trial with Niclosamide

Daewoong Pharmaceutical announced on 26 Oct 2020 that the collaborative clinical research agreement betwe...

October 30, 2020 | Friday | News
Asieris announces approval for Ph 1 trial of bladder cancer drug in Australia

Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new...

October 29, 2020 | Thursday | News
APRINOIA announces NMPA approval to initiate Ph 3 clinical trial

APRINOIA Therapeutics advancing a pipeline featuring diagnostic and therapeutic programs, collectively targeting brain d...

October 28, 2020 | Wednesday | News
Evado is pleased to announce the launch of Evado OnDemand.

The COVID Pandemic has dramatically disrupted the delivery of clinical trials. Sponsors now require instant  access...

October 26, 2020 | Monday | News
Oric Pharma teams up with Korean firm to expand precision oncology pipeline

ORIC Pharmaceuticals, Inc., a clinical-stage oncology company focused on developing treatments that address mechanisms o...

October 23, 2020 | Friday | News
Astellas to present new roxadustat data in anemia of CKD at ASN kidney week

Japan-based Astellas Pharma Inc. (Astellas) has announced that in collaboration with FibroGen and AstraZeneca, 42 roxadu...

October 19, 2020 | Monday | News
Astellas, Seagen announce positive results in Ph 2 pivotal trial of PADCEV

Japan-based Astellas Pharma Inc. and Seagen Inc. in the US have announced positive topline results from the second cohor...

October 14, 2020 | Wednesday | News
MVC obtains Taiwan government subsidy for initiating Ph 1 trial of COVID-19 vaccine

Taiwan based Medigen Vaccine Biologics Corporation (MVC), a biopharmaceutical company focusing on the development a...

October 13, 2020 | Tuesday | News
MedAlliance enrolls first two patients in PRISTINE study

MedAlliance a privately-owned medical technology company, headquartered in Nyon, Switzerland has announced the enrolment...

October 12, 2020 | Monday | News
Transgene, NEC, BostonGene collaborate for ovarian and head & neck cancers trials

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, a leader...

October 7, 2020 | Wednesday | News
Can-Fite announces positive ph III psoriasis interim data analysis

Can-Fite BioPharma Ltd., a biotechnology company based out in Israel, advancing a pipeline of proprietary small molecule...

October 6, 2020 | Tuesday | News